Improving Work Outcome in People With Recent-onset Schizophrenia
Schizophrenia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring work outcome, supported employment, social skills training, risperidone, cognition, first-episode schizophrenia
Eligibility Criteria
Inclusion Criteria: First major psychotic episode within 2 years of study entry RDC schizophrenia or schizoaffective disorder, mainly schizophrenic subtype Residence within commuting distance of UCLA Interest in trying to resume work or school Speaks English Exclusion Criteria: Known neurological disorder Significant and habitual drug abuse or alcoholism within 6 months of psychotic episode or evidence that substance abuse will be a prominent factor in course of illness Mental retardation Treatment with risperidone is contraindicated
Sites / Locations
- UCLA Neuropsychiatric Institute
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
1
2
Individual Placement and Support Plus Workplace Fundamentals Module
Brokered Vocational Rehabilitation